Recombinant Human PCLAF
Product Specifications
Product Name Alternative
HCV NS5A transactivated protein 9, HCV NS5A-transactivated protein 9, Hepatitis C virus NS5A transactivated protein 9, Hepatitis C virus NS5A-transactivated protein 9, KIAA0101, L5, NS5 ATP9, NS5ATP9, OEATC, OEATC 1, OEATC-1, OEATC1, Overexpressed in anaplastic thyroid carcinoma 1
UniProt
Q15004
Expression Region
1-111
Host
E.Coli
Tag
N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process
Applications
Western Blot, ELISA
Purity
Greater than 90% as determined by SDS-PAGE.
Form
Lyophilized powder
Reconstitution
Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.
Molecular Weight
12.1 kDa
Shipping Conditions
4°C with ice bag
Storage Conditions
The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.
Formulation
Lyophilized from a 0.2 μm filtered solution of 10 mM Hepes, 150 mM NaCl with 5% trehalose, pH 7.4.
Organism Species
Human
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
